Viewbix Announces Corporate Rebranding to Quantum X Labs: an Innovative Quantum and Technologies Company
Rhea-AI Summary
Viewbix (Nasdaq: VBIX) announced a corporate rebrand to Quantum X Labs with an expected name and ticker change to QXL effective April 30, 2026.
The company acquired a wholly owned quantum subsidiary in March 2026 and highlights a portfolio of IP, a pending AI‑Quantum Error Correction patent, and several minority stakes in specialized quantum subsidiaries.
Positive
- Name and ticker change to Quantum X Labs/QXL effective April 30, 2026
- Acquisition of wholly owned quantum subsidiary in March 2026 adds IP and specialist team
- Pending patent for AI‑Quantum Error Correction in the company portfolio
- Portfolio milestones include prototype breakthroughs in quantum gyroscopes and atomic clocks
Negative
- Multiple minority stakes (30%–46%) may limit operational control over key subsidiaries
- Strategic pivot to quantum may split management focus from legacy digital advertising business
News Market Reaction – VBIX
In the Apr 21 session, VBIX gained 6.13%, reflecting a notable positive market reaction. Argus tracked a peak move of +9.0% during that session. Argus tracked a trough of -26.4% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. Trading volume was above average at 1.9x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 30 | Nuclear simulation milestone | Positive | +2.0% | Subsidiary Nuclear Quantum advanced toward industry integration of simulation algorithms. |
| Mar 20 | NMR gyroscope patent | Positive | +4.4% | Filed provisional U.S. patent and secured equity-linked support for Quantum Gyro. |
| Mar 19 | Acquisition and placement | Positive | +0.0% | Closed Quantum X Labs deal and raised $1.4M via private placement. |
| Mar 05 | Acquisition closing terms | Positive | +16.1% | Detailed Quantum X Labs acquisition, IP portfolio, and equity-based consideration. |
| Mar 04 | Acquisition announcement | Positive | -4.0% | Announced closing of Quantum X Labs acquisition and related private placement. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent quantum-related milestones and acquisition news have often seen positive but variable single-day reactions, with one notable negative move on acquisition-closing disclosure.
Over the past two months, VBIX has transitioned from ad-tech into quantum technologies through the March 4, 2026 acquisition of Quantum X Labs and related financings. Subsequent releases highlighted a nuclear simulation milestone, an NMR gyroscope patent filing, and strategic positioning alongside other Nasdaq quantum names. Price reactions ranged from about flat to a 16.13% gain, suggesting that quantum-focused updates have generally supported the story but with uneven impact. Today’s full corporate rebranding formalizes this shift.
Key Terms
quantum error correction technical
quantum simulations technical
quantum sensing technical
quantum algorithms technical
gyroscope technical
atomic clocks technical
Markov Chain Monte Carlo technical
quantum cyber security technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Tel Aviv, Israel, April 21, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”). The rebranding represents the Company’s evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.
The Company is expected to change its name to Quantum X Labs Inc. and its ticker symbol to “QXL”, effective April 30th, 2026.
The new name and brand aims to position Quantum X Labs as a leading company to research, develop, and potentially commercialize innovative quantum solutions across key sectors, including navigation, precision timing, quantum algorithms, quantum error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. At the heart of this evolution is the Company’s wholly-owned subsidiary, Quantum X Labs Ltd., which the Company acquired in March 2026. This subsidiary operates as a dynamic quantum technology company that hires top quantum experts with a robust proprietary intellectual property portfolio, including a pioneering pending patent for AI-Quantum Error Correction and an active ecosystem of portfolio companies advancing breakthrough quantum applications.
Quantum X Labs Ltd.’s portfolio companies include:
Quantum Gyro: developing quantum-based gyroscope chip technology for unjammable, high-precision navigation systems designed to operate in GPS-denied environments. Quantum Gyro is a
Quantum Atom Accuracy: advancing next-generation atomic clocks based on novel light-modulation schemes to deliver ultra-high accuracy, robustness, and enhanced coherence for precision timing solutions. Quantum Atom Accuracy is a wholly-owned subsidiary of Nuclear Quantum.
Nuclear Quantum: progressing quantum-powered simulation algorithms targeted at nuclear and engineering industries, with recent milestones moving toward commercial engagement with leading simulation providers. Nuclear Quantum is a
QunatumQ Security: working on protecting assets by using quantum based cyber security. QuantumQ Security is a wholly-owned subsidiary of Quantum Gyro.
Quantum Transportation: developing transformer-based quantum decoder technology for advanced quantum error correction, including cloud-deployed neural decoders and IP licensing from Ramot at Tel Aviv University, with applications in transportation and secure systems. Quantum Transportation is a
CliniQuantum: applying quantum-enhanced methods (such as Markov Chain Monte Carlo) to drug discovery, clinical trial optimization, logistics, biomedicine, and security sectors. CliniQuantum is a
This rebranding builds on a series of technical milestones achieved by its portfolio companies in recent months, including patent filings, prototype breakthroughs in quantum gyroscopes and atomic clocks, and progress in quantum simulation and error-correction algorithms.
While advancing its quantum innovation, the Company will continue to support its legacy business of digital advertising and AI-driven computing solutions, through its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., which complement its expanding quantum portfolio.
About Viewbix Inc.
Viewbix Inc. and its subsidiaries are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence (AI) solutions. Quantum X Labs is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software and offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.
For more information about Viewbix, visit https://view-bix.com/
About Quantum X Labs
Quantum X Labs is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of advanced quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the Company’s future plans, strategies and expectations, including the research, development, and potential commercialization of innovative quantum solutions across key sectors, including computing technologies, navigation, precision timing, quantum algorithms, error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.
Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com
